Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice

The therapeutic sc"enario of metastatic renal cell cancer (mRCC) has noticeably increased, ranging from the most studied molecular target therapies to those most recently introduced, up to immune checkpoint inhibitors (ICIs). The most recent clinical trials with an ICI-based combination of mole...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Roberto, Michela, Botticelli, Andrea, Panebianco, Martina, Aschelter, Anna Maria, Gelibter, Alain, Ciccarese, Chiara, Minelli, Mauro, Nuti, Marianna, Santini, Daniele, Laghi, Andrea, Tomao, Silverio, Marchetti, Paolo
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100507/
https://ncbi.nlm.nih.gov/pubmed/33968762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.657639
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados